Oxthera investment
Webwww.oxthera.com Formerly Known As Ixion-Biotechnology Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Pharmaceuticals Biotechnology Primary Office C/O Ekonomi Klara Papper Post Office Box 1062 101 39 Stockholm Sweden +46 08-660 00 00 WebApr 5, 2024 · Given that this is a small and relatively unknown company with solid trial data, there is a strong investment angle to it. ... OxThera with its Oxabact, Amarna with its …
Oxthera investment
Did you know?
WebLatest from OxThera. 07 April 2024 Invitation to presentation of EQT AB’s Q1 Announcement 2024; 31 March 2024 Number of shares and votes in EQT; 30 March 2024 … WebOct 17, 2024 · OxThera announces the appointment of Dr. Bastian Dehmel as their new Chief Medical Officer. Dehmel joins OxThera after serving as Executive Medical Director and Global Development Leader for Amgen’s calcimimetic franchise. He has extensive experience in the life science sector, having led Medical Affairs and Clinical Development …
WebOxThera Sweden Prexton Therapeutics (Acq. Lundbeck) Switzerland Sanifit (Acq. Vifor Pharma) Spain SparingVision France SpliceBio Spain STAT Dx (Acq. Qiagen) Spain Synendos Switzerland TiGenix (Acq. Takeda Pharmaceuticals) Spain VarmX The Netherlands Vivet Therapeutics France/Spain Xeltis Switzerland/The Netherlands WebApr 18, 2014 · OxThera, a Swedish biopharmaceutical company, has received a SEK70 million ($10.6 million) investment led by new investor Kurma Partners. The fresh capital …
WebMc Callion Orla. Linked companies : Ultimovacs ASA. Summary. Presently, Mc Callion Orla is Head-Regulatory Affairs & QA at Ultimovacs ASA. He previously was Director-Regulatory Affairs at OxThera AB. Dr. Orla received a doctorate from Queen's University. Current positions of Mc Callion Orla. Name. Title. WebApr 16, 2014 · STOCKHOLM, April 16, 2014 /PRNewswire/ -- OxThera AB, a privately-held Stockholm-based biopharmaceutical company, today announced that a syndicate of new investors, led by Kurma Partners, including IdInvest Partners and Mayo Clinic, have agreed, together with OxThera's current shareholders, to invest a total of 70 MSEK in OxThera.
WebJul 5, 2024 · STOCKHOLM, Sweden, July 5, 2024 /PRNewswire/ -- OxThera AB, a Stockholm-based privately-held biopharmaceutical company today announced the appointment of Matthew Gantz as their new CEO. He...
WebOxThera is located in Stockholm, Stockholms Lan, Sweden. Who invested in OxThera? OxThera has 11 investors including EQT life science and … fiction novels for 7th gradersWebMar 12, 2024 · OxThera AB is a Swedish biotech company developing a new treatment for primary hyperoxaluria - a rare genetic and devastating disease with fatal outcomes. Currently pharmaceutical treatment is not available and median age of death is 30, if … fiction novels free on kindleWebMar 12, 2024 · OxThera AB is a Swedish biotech company developing a new treatment for primary hyperoxaluria (PH) - a rare genetic and devastating disease with fatal outcomes. Currently, pharmaceutical treatment... gre test anxietyWebApr 18, 2014 · OxThera, a Swedish biopharmaceutical company, has received a SEK70 million ($10.6 million) investment led by new investor Kurma Partners. The fresh capital will be used to continue clinical studies of the drug Oxabact, a … fiction nursingWebNov 29, 2016 · OxThera AB, a Stockholm-based privately-held biopharmaceutical company, announces today that it has agreed on a EURO 32 million investment to complete the … gre test art historyWebOxThera Chief Executive Officer 2015 Lifescience Pennsylvania Board Member Apr-2012 Swedish Orphan Biovitrum Board Member Feb-2009 to Jun-2016 BTG Executive Vice President, US May-2006 to Dec-2008 Acureon Pharmaceuticals CEO 2003 to 2005 Hydrabiosciences CEO Competencies Other Matthew GantzAchievements and … fiction nuoveWebNov 29, 2016 · OxThera's latest funding round was a Unattributed VC - III for $34.05M on November 29, 2016. View all funding This profile has not been claimed. You're more than your latest funding, tell our customers your company's story. Submit Your Analyst Briefing OxThera Investors OxThera has 13 investors. fiction obsessed